The NVCA formed the Cleantech Council to create a national working group that can identify regulatory and legislative issues critical to the development and commercialization of new Cleantech technologies. The "Council" helps formulate NVCA's policy agenda in the Cleantech arena, works to accelerate the growth of this emerging sector, and organizes select events that provide unique learning and deal opportunities for its members.
The Corporate Venture Group (CVG) was designed to provide information, education, networking, and on-line tools for corporate venture capitalists enabling them to accelerate the progress of innovation and growth through successful strategic venturing. Click here for information about the CVG.
Championed by NVCA Board Director Bruce Evans at Summit Partners, NVCA’s Growth Equity Group collects and disseminates information and shared practices relevant to growth equity investors. In addition, the Growth Equity Group supports members through political advocacy, education and networking opportunities. To learn more about growth equity investing and this member peer group, click here.
The Medical Innovation and Competitiveness Coalition (MedIC) educates policymakers on the critical role America’s medical innovation plays in the U.S. healthcare system and high quality job creation; where and how disruptive innovations are developed and; the challenges currently facing the medical innovation system. MedIC actively lobbies policymakers, educates stakeholders, and supports legislation to address the threats facing America’s medical innovation system. Founded as a partnership between NVCA member venture capital firms and their early-stage portfolio companies, the coalition aims to preserve U.S. leadership in medical innovation and ensure that America remains the primary incubator for global innovation. Venture capital firms who invest in the lifesciences and their portfolio companies are encouraged to join MedIC. To learn more, visit http://medic.nvca.org.